Article
Histone deacetylase inhibition in the treatment of heart disease
1 Jan 2008
Abstract excerpt
Recent work has demonstrated the importance of chromatin remodeling, especially histone acetylation, in the control of gene expression in the heart. Studies in preclinical models suggest that inhibition of histone deacetylase (HDAC) activity - using compounds that show promise in ongoing oncology trials - blunts pathologic growth of cardiac myocytes. Indeed, small-molecule inhibitors of HDACs are members of an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
